Multiple Sclerosis News Today

Tr1x gets OK for first-in-human trial of TRX319 for progressive MS

Tr1X has won an FDA green light for a clinical trial testing TRX319, a cell therapy designed to restore immune balance, for ...

Tr1X Announces FDA Clearance of IND Application for TRX319, a First-in-Class Allogeneic CAR-Tr1 Treg Cell Therapy for Progressive Multiple Sclerosis, and $50 Million in ...

On track to initiate TRX319 Phase 1/2a dose-escalation trial in early 2026TRX319 is an allogeneic CAR-Tr1 Treg cell therapy designed to pair ...